Ascentage Pharma Group International (ASPHF)
USD 6.45
(10.73%)
USD 6.45
(10.73%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.79 Billion CNY | 0.16% |
| 2022 | 1.79 Billion CNY | 65.34% |
| 2021 | 1.08 Billion CNY | 104.7% |
| 2020 | 529.69 Million CNY | 422.36% |
| 2019 | 101.4 Million CNY | 141.19% |
| 2018 | 42.04 Million CNY | 758.39% |
| 2017 | 4.89 Million CNY | 490.12% |
| 2016 | 830 Thousand CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 1.67 Billion CNY | 0.56% |
| 2023 Q4 | 1.79 Billion CNY | 0.55% |
| 2023 FY | 1.79 Billion CNY | 0.16% |
| 2023 Q3 | 1.78 Billion CNY | 6.55% |
| 2023 Q1 | 1.66 Billion CNY | -7.02% |
| 2022 Q4 | 1.79 Billion CNY | 0.45% |
| 2022 Q2 | 1.56 Billion CNY | 0.84% |
| 2022 Q1 | 1.54 Billion CNY | 42.78% |
| 2022 FY | 1.79 Billion CNY | 65.34% |
| 2022 Q3 | 1.78 Billion CNY | 14.31% |
| 2021 Q4 | 1.08 Billion CNY | 0.9% |
| 2021 FY | 1.08 Billion CNY | 104.7% |
| 2021 Q3 | 1.07 Billion CNY | 61.02% |
| 2021 Q2 | 667.4 Million CNY | 1.47% |
| 2021 Q1 | 657.74 Million CNY | 24.17% |
| 2020 Q2 | 288.08 Million CNY | 2.3% |
| 2020 FY | 529.69 Million CNY | 422.36% |
| 2020 Q4 | 529.69 Million CNY | 1.11% |
| 2020 Q3 | 523.88 Million CNY | 81.85% |
| 2020 Q1 | 281.61 Million CNY | 177.71% |
| 2019 Q3 | 94.21 Million CNY | -21.57% |
| 2019 Q2 | 120.11 Million CNY | -95.27% |
| 2019 Q1 | 2.53 Billion CNY | 5939.11% |
| 2019 FY | 101.4 Million CNY | 141.19% |
| 2019 Q4 | 101.4 Million CNY | 7.64% |
| 2018 Q3 | 2.11 Billion CNY | 0.0% |
| 2018 FY | 42.04 Million CNY | 758.39% |
| 2018 Q4 | 42.04 Million CNY | -98.01% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 FY | 4.89 Million CNY | 490.12% |
| 2016 FY | 830 Thousand CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 43.37 Million USD | -4039.891% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -30483.674% |
| CSL Limited | 12.18 Billion USD | 85.261% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -5932.138% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -237348.493% |
| BioStem Technologies, Inc. | 4.71 Million USD | -38011.57% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -8733.112% |
| Qrons Inc. | 351.84 Thousand USD | -510234.037% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1465691.837% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -3841.165% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -13715.463% |
| Skye Bioscience, Inc. | 4.61 Million USD | -38805.558% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | 310 Thousand USD | -579124.194% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -6981489.486% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Genscript Biotech Corporation | 417.73 Million USD | -329.837% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -284880.248% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -4257.923% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -43461.711% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -446733.263% |
| SQZ Biotechnologies Company | 27.47 Million USD | -6436.329% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -77098.183% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -189254.625% |
| Mesoblast Limited | 118.7 Million USD | -1412.712% |
| Marizyme, Inc. | 18.71 Million USD | -9493.138% |
| Genus plc | 233.1 Million USD | -670.311% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -61174.992% |
| Pharming Group N.V. | 171.54 Million USD | -946.72% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -202092.072% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -133542.184% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -239312.667% |
| ContraFect Corporation | 2.88 Million USD | -62225.408% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -1325189.511% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -124049.306% |
| IMV Inc. | 28.88 Million USD | -6116.595% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -31633.527% |
| MultiCell Technologies, Inc. | 202.58 USD | -886363311.985% |
| ONE Bio Corp. | 19.71 Million USD | -9007.751% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -3023.371% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -120026.697% |
| Q BioMed Inc. | 4.1 Million USD | -43588.645% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -5324.594% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -146078.119% |
| Biomind Labs Inc. | 735.54 Thousand USD | -244018.623% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -2554.523% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -59235.151% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -499078.505% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1268710.328% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -79408.064% |
| GB Sciences, Inc. | 1.75 Million USD | -101962.63% |
| Alpha Cognition Inc. | 1.22 Million USD | -147035.054% |
| HST Global, Inc. | 98.31 Thousand USD | -1826195.019% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -721834.304% |
| Halberd Corporation | 150 Thousand USD | -1196963.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -180119.464% |
| Agentix Corp. | 50 Thousand USD | -3591090.0% |
| Resverlogix Corp. | 6.49 Million USD | -27562.841% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -702423.944% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -8877.975% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -25287.293% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -66189.844% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -17560731.296% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -894940.774% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -74787.477% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -783007.492% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1207802.243% |
| Kadimastem Ltd | 891.22 Thousand USD | -201374.71% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -717615.503% |
| LadRx Corporation | 33.6 Thousand USD | -5342978.617% |
| Cell Source, Inc. | 9.25 Million USD | -19303.082% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -237348.493% |
| NovAccess Global Inc. | 2.19 Million USD | -81522.407% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -786141.609% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -850993.731% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -35934.417% |
| Mobile Lads Corp. | 484.28 Thousand USD | -370673.141% |
| CytoDyn Inc. | 30.07 Million USD | -5870.192% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -22861.69% |
| SYBLEU INC | 477.5 Thousand USD | -375940.838% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -37819.495% |
| International Stem Cell Corporation | 4.17 Million USD | -42877.382% |
| Bioxytran, Inc. | 1.92 Million USD | -93177.662% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -2876856.724% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -82232.753% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -21492.051% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -20815.492% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -115336.788% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -669898.134% |
| Neutra Corp. | 54.15 Thousand USD | -3315497.533% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -98019.945% |
| PureTech Health plc | 25.51 Million USD | -6938.237% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -146571.856% |
| IXICO plc | 472.02 Thousand USD | -380304.133% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -11483.737% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -2783.888% |
| CSL Limited | 12.18 Billion USD | 85.261% |
| Cellectis S.A. | 92.77 Million USD | -1835.398% |